[go: up one dir, main page]

NO178456C - Fremgangsmåte for fremstilling av farmasöytisk aktive piroksikam/syklodekstrinkomplekser - Google Patents

Fremgangsmåte for fremstilling av farmasöytisk aktive piroksikam/syklodekstrinkomplekser

Info

Publication number
NO178456C
NO178456C NO911216A NO911216A NO178456C NO 178456 C NO178456 C NO 178456C NO 911216 A NO911216 A NO 911216A NO 911216 A NO911216 A NO 911216A NO 178456 C NO178456 C NO 178456C
Authority
NO
Norway
Prior art keywords
pyroxycam
preparation
pharmaceutically active
cyclodextrin complexes
complexes
Prior art date
Application number
NO911216A
Other languages
English (en)
Other versions
NO911216L (no
NO178456B (no
NO911216D0 (no
Inventor
Fabio Carli
Paolo Chiesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO911216D0 publication Critical patent/NO911216D0/no
Publication of NO911216L publication Critical patent/NO911216L/no
Publication of NO178456B publication Critical patent/NO178456B/no
Publication of NO178456C publication Critical patent/NO178456C/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO911216A 1990-03-27 1991-03-25 Fremgangsmåte for fremstilling av farmasöytisk aktive piroksikam/syklodekstrinkomplekser NO178456C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19829A IT1241088B (it) 1990-03-27 1990-03-27 Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche

Publications (4)

Publication Number Publication Date
NO911216D0 NO911216D0 (no) 1991-03-25
NO911216L NO911216L (no) 1991-09-30
NO178456B NO178456B (no) 1995-12-27
NO178456C true NO178456C (no) 1996-04-03

Family

ID=11161628

Family Applications (1)

Application Number Title Priority Date Filing Date
NO911216A NO178456C (no) 1990-03-27 1991-03-25 Fremgangsmåte for fremstilling av farmasöytisk aktive piroksikam/syklodekstrinkomplekser

Country Status (24)

Country Link
US (1) US5164380A (no)
EP (1) EP0449167B1 (no)
JP (1) JPH04221314A (no)
KR (1) KR0175934B1 (no)
AT (1) ATE157883T1 (no)
AU (1) AU644417B2 (no)
CA (1) CA2039052C (no)
CZ (1) CZ280164B6 (no)
DE (1) DE69127566T2 (no)
DK (1) DK0449167T3 (no)
ES (1) ES2107430T3 (no)
FI (1) FI102461B1 (no)
GR (1) GR3025305T3 (no)
HU (1) HU217834B (no)
IE (1) IE910969A1 (no)
IL (1) IL97693A (no)
IT (1) IT1241088B (no)
MA (1) MA22089A1 (no)
NO (1) NO178456C (no)
NZ (1) NZ237583A (no)
PT (1) PT97176B (no)
RU (1) RU2034544C1 (no)
SK (1) SK279171B6 (no)
ZA (1) ZA912282B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254541A (en) * 1991-11-15 1993-10-19 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indole/cyclodextrin complex
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
IT1295289B1 (it) * 1997-10-07 1999-05-04 Telos S R L Co-macinati per uso cosmetico e dermatologico
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
HK1039458B (zh) 1998-05-29 2006-09-01 Skyepharma Canada Inc. 熱保護微粒組合物及其最終蒸汽滅菌的方法
AU767154B2 (en) * 1998-11-20 2003-10-30 Skyepharma Canada Inc. Dispersible phospholipid stabilized microparticles
US20060073188A1 (en) * 1999-03-31 2006-04-06 Pierre Fabre Medicament Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same
ITMI20012749A1 (it) * 2001-12-21 2003-06-21 Chiesi Farma Spa Procedimento per la preparazione mediante trattamento con microonde di composti di inclusione tra farmaco e ciclodestrine e prodotti ottenut
FR2868315B1 (fr) * 2004-04-01 2006-07-14 Pierre Fabre Medicament Sa Procede de preparation d'un compose d'inclusion soluble de substances actives dans une molecule hote avec l'aide d'un agent d'interaction par fluide supercritique
PT1729813E (pt) 2004-04-01 2011-07-12 Pf Medicament Complexos de inclusão obtidos utilizando um processo com co2 supercrítico e um agente de interacção com o complexo
US8715731B2 (en) * 2006-03-22 2014-05-06 Isp Investments Inc. Process of reducing the bitter taste of water soluble actives by co-grinding the active with β cyclodextrin
JP5552400B2 (ja) * 2010-09-07 2014-07-16 東亜薬品株式会社 生薬類の苦味・不快味をマスキングした顆粒剤、及び口腔内速崩壊錠
CN102008450B (zh) * 2010-12-10 2013-01-30 杭州艾瑞莎生物医药科技有限公司 一种药物-环糊精纳米颗粒及其制备方法
ITMI20120092A1 (it) 2012-01-26 2013-07-27 Micro Macinazione S A Compositi di inclusione farmaco-carrier preparati con processo di attivazione meccano-chimica mediante mulini a getto di fluido ad alta energia
ITUB20161027A1 (it) * 2016-02-24 2017-08-24 Altergon Sa Preparazioni farmaceutiche oromucosali ad elevata biodisponibilita’ a base di ciclodestrina e sucralosio
US10532102B2 (en) 2016-08-19 2020-01-14 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical composition and methods of uses
GB202105833D0 (en) * 2021-04-23 2021-06-09 Nacamed As Silicon particles for drug delivery
KR102337124B1 (ko) * 2021-05-13 2021-12-10 (주)바이오제닉스 탈모 개선용 복합 파우더 및 이를 포함하는 모발용 화장료 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
JPS6165805A (ja) * 1984-09-10 1986-04-04 Nippon Ekishiyou Kk 防殺虫フイルムの製造方法
US4564614A (en) * 1984-10-11 1986-01-14 Pfizer Inc. Antiinflammatory methods
US4672061A (en) * 1985-01-28 1987-06-09 Pfizer Inc. Antiinflammatory compositions and methods
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US4888343A (en) * 1986-09-15 1989-12-19 Bristol-Myers Company Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
US5081118A (en) * 1987-10-26 1992-01-14 Pfizer Inc. Benzothiazine dioxide derivatives
US5068226A (en) * 1987-12-07 1991-11-26 Cyclex, Inc. Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
IT1216686B (it) * 1988-04-01 1990-03-08 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
CA1321192C (en) * 1988-04-20 1993-08-10 Abdul Majid Inclusion complexes of cyclodextrins by agglomeration
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione

Also Published As

Publication number Publication date
FI102461B (fi) 1998-12-15
FI911448A7 (fi) 1991-09-28
DE69127566D1 (de) 1997-10-16
AU7383891A (en) 1991-10-03
EP0449167B1 (en) 1997-09-10
PT97176B (pt) 1998-07-31
EP0449167A1 (en) 1991-10-02
CA2039052A1 (en) 1991-09-28
DE69127566T2 (de) 1998-02-12
DK0449167T3 (da) 1998-03-09
CS9100833A2 (en) 1991-10-15
IL97693A0 (en) 1992-06-21
KR910016333A (ko) 1991-11-05
IL97693A (en) 1995-03-30
JPH04221314A (ja) 1992-08-11
MA22089A1 (fr) 1991-10-01
PT97176A (pt) 1991-11-29
AU644417B2 (en) 1993-12-09
IT1241088B (it) 1993-12-29
NZ237583A (en) 1992-08-26
HU911016D0 (en) 1991-10-28
US5164380A (en) 1992-11-17
IT9019829A0 (it) 1990-03-27
FI911448A0 (fi) 1991-03-26
IT9019829A1 (it) 1991-09-27
CA2039052C (en) 2002-07-30
SK279171B6 (sk) 1998-07-08
GR3025305T3 (en) 1998-02-27
FI102461B1 (fi) 1998-12-15
ZA912282B (en) 1991-12-24
NO911216L (no) 1991-09-30
KR0175934B1 (ko) 1999-03-20
IE910969A1 (en) 1991-10-09
CZ280164B6 (cs) 1995-11-15
ES2107430T3 (es) 1997-12-01
HU217834B (hu) 2000-04-28
NO178456B (no) 1995-12-27
NO911216D0 (no) 1991-03-25
HUT60738A (en) 1992-10-28
ATE157883T1 (de) 1997-09-15
RU2034544C1 (ru) 1995-05-10

Similar Documents

Publication Publication Date Title
NO178456C (no) Fremgangsmåte for fremstilling av farmasöytisk aktive piroksikam/syklodekstrinkomplekser
EP0214647A3 (en) Inclusion complexes of 7-isopropoxy-isoflavone and cyclodextrins, process for their preparation and pharmaceutical preparations containing these complexes
YU43694A (sh) Magnezijum omeprazol i postupak za dobijanje ovog jedinjenja
CA2162716A1 (en) Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, its preparation and use
ATE144523T1 (de) Glykosylierte arzneimittel-vorstufen, verfahren zu ihrer herstellung und ihre verwendungen
LU90960I2 (fr) Voriconazole les sels et dérivés pharmaceutiquement acceptables et en particulier le complexe cyclodextrine de celui-ci
ES486109A1 (es) Procedimiento para fabricar complejos de inclusion de manza-nilla en ciclodextrina
RU95105977A (ru) Комплексы включения солей нимезулида с циклодекстринами, способ их получения, фармацевтические композиции на их основе и способ лечения
HU9203649D0 (en) Method for producing inclusion compounds of nimesulide with cyclodextrines and pharmaceutical preparatives containing these compounds
FI92195C (fi) Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi
DE59107336D1 (de) Oligosaccharidderivate und deren Verwendung in Heilmitteln
GB1341794A (en) Medicament for the treatment of hepatic disorders
NL7416873A (nl) Werkwijze ter bereiding van farmaceutische pre- en met anti-allergische werking, de aldus egen gevormde voortbrengselen, alsmede ijze ter bereiding van 5:6-benzo-gamma derivaten.
EG20082A (en) Process for preparing of octadecyl-(2-N-methylpiperidino)-ethyl-phosphate
NO174963C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 8-fluorantracyklinglucosider
IT1115132B (it) Derivati del 6,7 benzomorfano loro preparazione e loro applicazione in terapeutica
IT1237783B (it) Derivati di ferro-albumina biodisponibile, loro procedimento di preparazione e relative composizioni farmaceutiche.
CA2027773A1 (en) Treatment of shock by cyclodextrins and their derivatives
AU2349588A (en) Cephalosporin derivatives with improved pharmacokinetics, process for their preparation, pharmaceutical compositions in which they are present and synthesis intermediate
IT1228462B (it) Derivati del 1 arilsolfonil pirrolidin 2 tione oppure del 1 arilsolfonil piperidin 2 tione, loro procedimento di preparazione e loro impiego come medicinali.
IT8619969A0 (it) Derivati del ferro, procedimento per la loro produzione e relative composizioni farmaceutiche
AU665546B2 (en) Conjugates for treating gastrointestinal tumours
CA502836A (en) Process for producing dextran products having substantially uniform molecular size, for pharmaceutical and therapeutical preparations
GB1531980A (en) Triazolylbenzophenone derivatives and preparation thereof
CA862750A (en) Hydroxypropyl methyl cellulose ethers, a process for preparing the same, and compositions utilizing such ethers

Legal Events

Date Code Title Description
MK1K Patent expired